<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01212549</url>
  </required_header>
  <id_info>
    <org_study_id>524270910</org_study_id>
    <nct_id>NCT01212549</nct_id>
  </id_info>
  <brief_title>Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma</brief_title>
  <acronym>IMCXvsCIMT</acronym>
  <official_title>Open Label, Randomized Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma of the Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ioannina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ioannina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effectiveness of two application schemes of cryosurgery during a 5 week course
      of topical imiquimod i.e. cryosurgery at the end of the second week of imiquimod followed by
      3 more weeks of imiquimod (immunocryosurgery) versus cryosurgery at day 0 followed by 5 weeks
      of topical imiquimod (cryoimmunotherapy)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of efficacy

        -  Number of patients: N=40

        -  Arms: Two equal arms (20 patients each)

        -  Inclusion criteria: Basal cell carcinoma of the skin proven with biopsy

        -  Exclusion criteria: (1) Size of the tumors &gt;5cm; (2) Distance from the eyelid &lt;0,5cm;
           (3)Number of tumors &gt;5

        -  Interim analysis: When at least 10 patients are included in each arm or at the end of
           the first year of the study

      The patients will be randomized in 2 groups Group 1 (Immunocryosurgery) and Group 2
      (Cryoimmunotherapy)

      Treatment protocols:

      Group 1 (Immunocryosurgery): Patients will apply imiquimod daily for 14 days on the tumor and
      a rim of 2mm around the tumor. On day 14 a session of mild cryosurgery (2 cycles of 15
      seconds, with open spray liquid nitrogen) will be applied and the patients will continue
      application of imiquimod for another 3 weeks before being evaluated again.

      Group 2 (Cryoimmunotherapy): Patients will be submitted into cryosurgery (2 cycles of 15
      seconds, with open spray liquid nitrogen) and subsequently will apply imiquimod on the tumor
      and a rim of 2mm around the tumor for 5 weeks in total. They will be evaluated in week 2 and
      5.

      Patients from both groups will be evaluated at 1, 3, 6, 12 months after termination of
      imiquimod treatment. In case of clinical relapse, it will be confirmed by biopsy and all the
      patients will treated with immunocrysurgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the efficacy of immunocryosurgery and cryoimmunotherapy</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Basal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Immunocryosurgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 weeks imiquimod, cryosurgery (open spray liquid nitrogen, 2 cycles, 15 secs each), 3 weeks imiquimod</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cryoimmunotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cryosurgery (open spray liquid nitrogen, 2 cycles, 15 secs each), 5 weeks imiquimod</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Immunocryosurgery</intervention_name>
    <description>2 weeks imiquimod, cryosurgery (open spray liquid nitrogen, 2 cycles, 15 secs each), 3 more weeks imiquimod</description>
    <arm_group_label>Immunocryosurgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cryoimmunotherapy</intervention_name>
    <description>Cryosurgery(open spray liquid nitrogen, 2 cycles, 15 secs each), followed by 5 weeks imiquimod</description>
    <arm_group_label>Cryoimmunotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biopsy proven basal cell carcinoma of the skin

          -  Size &lt;5cm

          -  Number of tumors &lt;5 cm

          -  Distance from eyelids, mouth 0,5cm

        Exclusion Criteria:

          -  Size &gt;5cm

          -  Number of tumors &gt; or =5

          -  Distance from eyelids or mouth &lt; or =0.5cm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ioannis D Bassukas, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical School, University of Ioannina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department for Skin and Venereal Diseases, University Hospital</name>
      <address>
        <city>Ioannina</city>
        <zip>45110</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Gaitanis G, Nomikos K, Vava E, Alexopoulos EC, Bassukas ID. Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application. J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1427-31. doi: 10.1111/j.1468-3083.2009.03224.x. Epub 2009 Jun 25.</citation>
    <PMID>19555364</PMID>
  </reference>
  <reference>
    <citation>Bassukas ID, Gaitanis G. Combination of cryosurgery and topical imiquimod: does timing matter for successful immunocryosurgery? Cryobiology. 2009 Aug;59(1):116-7. doi: 10.1016/j.cryobiol.2009.04.011. Epub 2009 May 6.</citation>
    <PMID>19426725</PMID>
  </reference>
  <reference>
    <citation>Bassukas ID, Gamvroulia C, Zioga A, Nomikos K, Fotika C. Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna. Int J Dermatol. 2008 May;47(5):519-21. doi: 10.1111/j.1365-4632.2008.03562.x.</citation>
    <PMID>18412875</PMID>
  </reference>
  <reference>
    <citation>Gaitanis G, Mitsou G, Tsiouri G, Alexis I, Bassukas ID. Cryosurgery during imiquimod cream treatment (&quot;immunocryosurgery&quot;) for Bowen's disease of the skin: a case series. Acta Derm Venereol. 2010 Sep;90(5):533-4. doi: 10.2340/00015555-0896.</citation>
    <PMID>20814639</PMID>
  </reference>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2010</study_first_submitted>
  <study_first_submitted_qc>September 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2010</study_first_posted>
  <last_update_submitted>August 31, 2011</last_update_submitted>
  <last_update_submitted_qc>August 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ioannina</investigator_affiliation>
    <investigator_full_name>Ioannis Bassukas</investigator_full_name>
    <investigator_title>Associate Professor of Dermatology</investigator_title>
  </responsible_party>
  <keyword>basal cell carcinoma</keyword>
  <keyword>cryosurgery</keyword>
  <keyword>imiquimod</keyword>
  <keyword>immunocryosurgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Imiquimod</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

